Arovella Therapeutics
Arovella Therapeutics Logo
Logos are displayed for identification only. Logokit is not affiliated with, endorsed by, or sponsored by the companies shown.
About Arovella Therapeutics
Arovella Therapeutics Ltd is a biotechnology company specializing in the development of innovative cell therapies for cancer. The company focuses on harnessing invariant natural killer T (iNKT) cells, developing chimeric antigen receptor (CAR)-iNKT cell therapies targeting blood cancers such as B cell lymphomas and leukaemias, as well as solid tumors. Its pipeline includes ALA-101, an off-the-shelf CAR-iNKT cell therapy targeting CD19+ cancers, ALA-105 targeting Claudin 18.2 in various solid tumors, and IL-12-TM for enhancing anti-tumor activity. Arovella aims to improve patient access to advanced cancer treatments through its proprietary cell therapy platform.
Address
Corporate One, 84 Hotham Road
Preston, 3072
Australia
Year founded
2000
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Add Arovella Therapeutics logo and brand data to your app or website
Embed this logo using a simple HTML tag, or access structured brand data with a single call to our API.
<img src="https://img.logokit.com/arovella.com" />
Report inaccurate data
Request an update to help us keep the brand up-to-date.
